RT Journal Article
SR Electronic
T1 Frequency of hospitalization of infants with bronchiolitis during 2017 in Puerto Madryn, Argentina
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.28.21250671
DO 10.1101/2021.01.28.21250671
A1 Damián L. Taire
A1 Bruno A. Pazos
YR 2021
UL http://medrxiv.org/content/early/2021/01/31/2021.01.28.21250671.abstract
AB Introduction Bronchiolitis is considered the most frequent disease in infants and still represents an important cause of morbidity and mortality worldwide. Despite its viral etiology, socioeconomic variables could influence the disease outcome. We aimed to determine the frequency of hospital discharge for bronchiolitis in a local Hospital in the city of Puerto Madryn, in the province of Chubut, Patagonia Argentina.Population and methods We performed a cross-sectional study that analyzed all hospitalized patients discharged for bronchiolitis in Hospital “Dr. Andrés R. Isola” during the year 2017 and based on data provided by the hospital administrative staff. The study variables were the length of stay, readmission rate and place of origin of hospitalized patients.Results A total of 120 patients were included. The median age was 4.45 months (3.9-5). The mean length-of-stay (LOS) was 7.30 days (5.52-9.08). Of the total number of patients, 24 (20%) had a LOS ≤3 days and 96 (80%) a >3 days. One hundred patients (88.33%) had no hospital readmissions and 10 patients (8.33%) had hospital readmissions. The median age of patients with readmissions was 4.2 months (2.69-5.71). The mean LOS during readmission was 17.3 days (5.25-29.35). Of the 120 hospitalized children, 100 infants (83.33%) live in areas identified as having “unsatisfied basic needs” in Puerto Madryn.Conclusions The overcrowding as a result of the demographic transformation on the frequency of hospitalization of infants with bronchiolitis was homogeneous within the Puerto Madryn population with “unsatisfied basic needs”.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding: None.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The protocol was approved (15/12/2017) by a Sub-Committee of Investigation Ethics from the Committee of Bioethics from the Northern Programmatic Area of Chubut province.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the aggregate data generated and analysed during the current study are included in this published article. The data sets are available from the corresponding author upon request.LOSlength-of-stayALRTIacute lower respiratory tract infectionsICD-10International Classification of Diseases and Related Health Problems, tenth revisionIQRinterquartile rangeCIconfidence intervalUBNunsatisfied basic necessitiesEWepidemiological week